Holen Sie sich die Stockscreener-App
57.31
2.32%
1.30
Handel nachbörslich:
57.31
Schlusskurs vom Vortag:
$56.01
Offen:
$55.6
24-Stunden-Volumen:
157.55K
Relative Volume:
0.45
Marktkapitalisierung:
$1.20B
Einnahmen:
$486.82M
Nettoeinkommen (Verlust:
$18.78M
KGV:
-119.40
EPS:
-0.48
Netto-Cashflow:
$100.45M
1W Leistung:
-2.88%
1M Leistung:
-0.90%
6M Leistung:
-14.78%
1J Leistung:
-12.41%
1-Tages-Spanne:
$55.55
$57.67
1-Wochen-Bereich:
$55.55
$60.44
52-Wochen-Spanne:
$48.20
$70.81
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
ANI Pharmaceuticals to Present at Guggenheim's Inaugural - GlobeNewswire
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November - StockTitan
F M Investments LLC Buys Shares of 61,782 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Stock: Acting Like It Is Being Acquired (NASDAQ:ANIP) - Seeking Alpha
Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline - Yahoo Finance
ANI Pharmaceuticals (ANIP) to Release Quarterly Earnings on Friday - MarketBeat
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - GlobeNewswire
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 9.7% in October - MarketBeat
Assenagon Asset Management S.A. Grows Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06% - GlobeNewswire
ANI Pharmaceuticals introduces generic Estradiol Gel By Investing.com - Investing.com South Africa
ANI Pharmaceuticals introduces generic Estradiol Gel - Investing.com
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 - The Manila Times
ANI Pharmaceuticals to Present New Data Highlighting - GlobeNewswire
ANI Pharmaceuticals price target raised to $62 from $60 at Truist - Yahoo Finance
Critical Insights From ANI Pharmaceuticals Analyst Ratings: What You Need To Know - Benzinga
ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $62.00 at Truist Financial - MarketBeat
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
Avadel Obtains FDA Nod for Label Expansion Of Narcolepsy Drug Lumryz - Benzinga
Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year? - Yahoo Finance
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $14,297.50 in Stock - MarketBeat
Ani Pharmaceuticals' sr. vp sells $14,297 in stock By Investing.com - Investing.com Canada
Ani Pharmaceuticals' sr. vp sells $14,297 in stock - Investing.com India
ANI Pharmaceuticals (NASDAQ:ANIP) Now Covered by Piper Sandler - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential - Yahoo Finance
ANI Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
ANI Pharma stock earns bull at Piper Sandler (NASDAQ:ANIP) - Seeking Alpha
Piper Sandler Initiates Coverage on ANI Pharmaceuticals (NASDAQ:ANIP) - MarketBeat
Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights - Benzinga
ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market - Seeking Alpha
While shareholders of ANI Pharmaceuticals (NASDAQ:ANIP) are in the black over 3 years, those who bought a week ago aren't so fortunate - Simply Wall St
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Millennium Management LLC - MarketBeat
Algert Global LLC Decreases Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance - GlobeNewswire
Dimensional Fund Advisors LP Boosts Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 8.3% in September - MarketBeat
Maverick Capital Ltd. Has $1.18 Million Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? - Yahoo Finance
Drugs for Arrhythmia Market Demand and Business Outlook | Sanofi, Boehringer Ingelheim Pharmaceuticals, Inc, ANI Pharmaceuticals – Cauverynews - Cauverynews
ANI Pharmaceuticals launches generic Ketoconazole Shampoo - Investing.com India
ANI Pharmaceuticals launches generic Ketoconazole Shampoo By Investing.com - Investing.com Canada
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2% - The Manila Times
American Century Companies Inc. Purchases 49,717 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Quotes, Forecast and News Summary - Benzinga
Renaissance Technologies LLC Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
It makes sense and dollars to buy ANI Pharmaceuticals Inc (ANIP) stock - SETE News
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):